サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433306

神経血管塞栓装置の世界市場：2023～2030年

Global Neurovascular Embolization Devices Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 130 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
神経血管塞栓装置の世界市場：2023～2030年
出版日: 2023年12月07日
発行: Orion Market Research
ページ情報: 英文 130 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経血管塞栓装置の市場規模は、2023～2030年の予測期間中にCAGR 6.3％で成長すると予測されています。市場成長の背景には、脳動脈瘤の有病率の増加や、認知機能の永続的な喪失や神経障害など、頭蓋内動脈瘤に伴う深刻なリスクがあります。脳動脈瘤はすべての年齢層で同じように発生するが、35歳以上はリスクが高いです。脳動脈瘤財団（BAF）によると、米国では推定670万人、50人に1人が未破裂の脳動脈瘤を持っています。脳動脈瘤は35歳から60歳の人に最も多く見られるが、子供にも発生することがあります。これらすべての要因が、メーカーに斬新で最先端の神経血管塞栓装置を導入させ、食品医薬品局（FDA）の認可を世界的に上昇させています。例えば、2022年3月、末梢血管、神経血管、心臓病市場向けの革新的な製品を開拓する医療機器企業であるArtio Medical, Inc.は、末梢血管閉塞のための次世代製品であるsolus gold塞栓装置の米国FDA認可を取得しました。

セグメント別展望

血管塞栓用コイルは神経血管塞栓装置の世界市場で大きなシェアを占めると予想されます。

製品の中でも、塞栓コイルは、これまで手術不可能とされていた脳動脈瘤の治療を可能にすることから、世界の神経血管塞栓装置市場でかなりのシェアを占めると予想されています。Beaumont Health Systemが発表した研究によると、頸部の小さな動脈瘤のコイル塞栓術は、頸部の大きな動脈瘤や巨大動脈瘤の塞栓術よりも良好な結果を示しています。長期追跡調査により、コイル塞栓術で治療された動脈瘤の80％以上で永久的な成功が示されています。業界各社によって開発された神経疾患治療用製品の新興国市場は、市場の成長を牽引しています。例えば、2023年7月、 Boston Scientific Corp.は、低侵襲末梢塞栓術用のエンボルドソフトコイルとパッキングコイルを発売しました。

地域別展望

世界の神経血管塞栓装置市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他のアジア太平洋）、その他の地域（中東・アフリカ、中南米）を含む地域別にさらに区分されます。なかでもアジア太平洋は、高齢化、神経疾患、新興国の可処分所得の増加がアジア太平洋の市場成長を牽引していることから、世界市場で突出したシェアを占めると予想されます。

北米地域は神経血管塞栓装置の世界市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の市場成長を支える主な要因としては、高齢化人口の増加、脳動脈瘤、頸動脈狭窄症、脳卒中などの神経血管疾患の発生率の増加などが挙げられ、北米では神経血管塞栓装置の必要性が高まっています。米国疾病予防管理センター（CDC）によると、2022年には米国で毎年79万5,000人以上が脳卒中に遭遇するといいます。約61万人が初発または新規の脳卒中であると言われています。約18万5,000人の脳卒中は、4人に1人が脳卒中の既往者です。脳卒中全体の約87.0％は虚血性脳卒中であり、脳への血流が遮断されます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • B. Braun Melsungen AG
  • Cerenovus Inc.
  • Medtronic plc
  • Stryker Corp.
  • 主要戦略分析

第4章 市場セグメンテーション

  • 神経血管塞栓装置の世界市場：製品別
    • 塞栓コイル
    • 血流転換装置
  • 神経血管塞栓装置の世界市場：用途別
    • 病院
    • 専門クリニック

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • その他の地域

第6章 企業プロファイル

  • Acandis GmbH
  • Balt Extrusion SA
  • Boston Scientific Corp.
  • DePuy Synthes（Johnson & Johnson Services, Inc.）
  • Integra Lifesciences Holdings Corp.
  • MicroVention Inc.
  • Penumbra Inc.
  • Phenox GmbH
  • Resonetics LLC
  • Spartan Micro, Inc.
  • Terumo Medical Corp.
図表

LIST OF TABLES

  • 1. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL NEUROVASCULAR EMBOLIC COILS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL FLOW DIVERSION NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 5. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR SPECIALTY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 9. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 11. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 13. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 14. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 17. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL NEUROVASCULAR EMBOLIC COILS MARKET SHARE, 2022 VS 2030 (%)
  • 3. GLOBAL FLOW DIVERSION NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022 VS 2030 (%)
  • 5. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR SPECIALTY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. US NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 9. CANADA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 10. UK NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. FRANCE NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. GERMANY NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. ITALY NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. SPAIN NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. REST OF EUROPE NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. INDIA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CHINA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. JAPAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SOUTH KOREA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027923

Global Neurovascular Embolization Devices Market Size, Share & Trends Analysis Report by Product (Embolic Coils and Flow Diversion Devices), and by End-Use (Hospitals and Specialty Clinics), Forecast Period (2023-2030)

The global neurovascular embolization devices market is anticipated to grow at a CAGR of 6.3% during the forecast period (2023-2030). The market growth is attributed to the increasing prevalence of cerebral aneurysms, and severe risks associated with intracranial aneurysms, such as permanent loss of cognitive functions and neurological disorders. Brain aneurysm is equally prevalent in individuals of all age groups, however individuals 35 years and above are at high risk. According to the Brain Aneurysm Foundation (BAF), an estimated 6.7 million people in the US have an unruptured brain aneurysm or 1 in 50 people. Brain aneurysms are most prevalent in people aged between 35 to 60 years, however it may occur in children as well. Most aneurysms is developed after the age of 40 years. Women are more likely than men to have a brain aneurysm (3:2 ratio). All these factors have compelled manufacturers to introduce novel and cutting-edge neurovascular embolization devices and rising Food and Drug Administration (FDA) clearance globally. For instance, in March 2022, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, received US FDA clearance for its solus gold embolization device, a next-generation product for peripheral vascular occlusion.

Segmental Outlook

The global neurovascular embolization devices market is segmented on the product, and end-use. Based on the product, the market is sub-segmented into embolic coils and flow diversion devices. Further, based on end-use, the market is sub-segmented into hospitals and specialty clinics. Among the end-use, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the easy availability, offer flexible scheduling options, appealing to individuals with busy lifestyles who are seeking quick and effective treatments.

Embolic Coils Sub-Segment is Anticipated to Hold a Considerable Share of the Global Neurovascular embolization devices Market

Among the products, the embolic coils sub-segment is expected to hold a considerable share of the global neurovascular embolization devices market, owing to the allowing treatment of cerebral aneurysms that previously were considered inoperable. As per the study published by Beaumont Health System, coil embolization of small aneurysms with small neck has better results than embolization of large or giant aneurysm with wide necks. Long term follow up has shown permanent success in more than 80% of aneurysms treated with coil embolization. The advancements in the products designed for the treatment of neurological disorders developed by the industry market players drive the growth of the market. For instance, in July 2023, Boston Scientific Corp., launched its Embold soft and packing coils for minimally invasive peripheral embolization procedures. Similarly, in June 2023, the US FDA cleared the coils. Embold coils contain a delivery mechanism that allows users to detach the coil easily.

Regional Outlook

The global neurovascular embolization devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market around the globe, owing to the growing aging population, neurological disorders, and the rising disposable income in emerging economies are driving the market growth in the Asia-Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Neurovascular Embolization Devices Market

Among all the regions, the North America region is anticipated to grow at a considerable CAGR over the forecast period. The primary factor supporting the regional market growth includes the growing the aging population, increasing incidence of neurovascular diseases such as brain aneurysm, carotid stenosis, and stroke, which increases the requirement of neurovascular embolization devices in Noth America. According to the Centers for Disease Control and Prevention (CDC), in 2022, yearly more than 795,000 people in the US encountered with a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes nearly 1 in 4 are in people who have had a previous stroke. About 87.0% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. Every 40 seconds, someone in the US has a stroke. Every 3 minutes and 14 seconds, someone dies of a stroke.

Market Players Outlook

The major companies serving the global neurovascular embolization devices market include B. Braun Melsungen AG, Cerenovus Inc., Medtronic plc, Stryker Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, Fluidx Medical Technology, Inc. released the IMPASS Embolic Device in in-vivo research related to middle meningeal artery (MMA) embolization which can be used to treat chronic subdural hematomas (CSDH) on the surface of the brain.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global neurovascular embolization devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. B. Braun Melsungen AG
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Cerenovus Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Medtronic plc
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Stryker Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Neurovascular Embolization Devices Market by Product
    • 4.1.1. Embolic Coils
    • 4.1.2. Flow Diversion Devices
  • 4.2. Global Neurovascular Embolization Devices Market by End-Use
    • 4.2.1. Hospitals
    • 4.2.2. Specialty Clinics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Acandis GmbH
  • 6.2. Balt Extrusion SA
  • 6.3. Boston Scientific Corp.
  • 6.4. DePuy Synthes (Johnson & Johnson Services, Inc.)
  • 6.5. Integra Lifesciences Holdings Corp.
  • 6.6. MicroVention Inc.
  • 6.7. Penumbra Inc.
  • 6.8. Phenox GmbH
  • 6.9. Resonetics LLC
  • 6.10. Spartan Micro, Inc.
  • 6.11. Terumo Medical Corp.